NCT02172274View on ClinicalTrials.gov

BI 10773 Administered as Oral Solution to Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

July 31, 2008

Conditions
Healthy
Interventions
DRUG

[14C]-BI 10773 - oral solution

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY